Skip to main content
NIH funding notice RFA-MD-24-007

Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)

Closed on November 17, 2025.

Posted
March 8, 2024
Close date
November 17, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $285,444 in first-year total cost, median $285,444.

Most frequent study sections

  1. Special Emphasis Panel[ZMD1 JT (J1)]1

Most frequent institutions

  1. PRECISION QUANTOMICS INC1
Competing awards under RFA-MD-24-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Recombinant human enzymes for characterization of drug metabolism in US patient populations1R41TR005541-01PRASAD, BHAGWATWATSON, CHRISTY J.W.PRECISION QUANTOMICS INC, WA$285,444ZMD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.